Vaksin Covid-19: Perbedaan antara revisi
Konten dihapus Konten ditambahkan
kTidak ada ringkasan suntingan Tag: VisualEditor Suntingan perangkat seluler Suntingan peramban seluler |
kTidak ada ringkasan suntingan Tag: VisualEditor Suntingan perangkat seluler Suntingan peramban seluler |
||
Baris 218:
* Argentina<ref>{{Cite news|last=Laing|first=Aislinn|date=31 Desember 2020|title=Argentine regulator approves AstraZeneca/Oxford COVID-19 vaccine -AstraZeneca|url=https://www.reuters.com/article/us-health-coronavirus-argentina-astrazen/argentine-regulator-approves-astrazeneca-oxford-covid-19-vaccine-astrazeneca-idUSKBN29421P|work=Reuters|access-date=14 Januari 2021}}</ref>
* India<ref name=":1">{{Cite news|last=Pasricha|first=Arjana|date=3 Januari 2021|title=India Approves AstraZeneca and Locally Developed Vaccine|url=https://www.voanews.com/covid-19-pandemic/india-approves-astrazeneca-and-locally-developed-vaccine|work=VOA News|access-date=14 Januari 2021}}</ref>
*Indonesia
* El Salvador<ref>{{Cite news|last=|first=|date=31 Desember 2020|title=El Salvador greenlights AstraZeneca, Oxford University COVID-19 vaccine|url=https://www.reuters.com/article/us-health-coronavirus-el-salvador-vaccin/el-salvador-greenlights-astrazeneca-oxford-university-covid-19-vaccine-idINKBN2942HQ|work=Reuters|access-date=14 Januari 2021}}</ref>
* Republik Dominika
|